Literature DB >> 32768799

Trends and predictors of survival for small cell carcinoma of the cervix uteri: A SEER population study.

Tao Song1, Qiuyan Wan2, Min Fang1, Wenming Zhan1, Hong'en Xu3, Huafeng Shou4.   

Abstract

OBJECTIVE: Small cell carcinoma of the cervix uteri (SCCC) is an uncommon cancer associated with unsatisfactory survival outcomes. We aimed to investigate the incidence and prognostic factors of survival in SCCC patients using the Surveillance, Epidemiology, and End Results database.
METHODS: Eligible patients with histopathologic diagnoses of SCCC were identified between 2004 and 2015. Overall survival (OS) and cause-specific survival (CSS) for the included patients were calculated using the Kaplan-Meier method. Univariate and multivariate analyses of clinical factors were performed using Cox proportional hazard regression models.
RESULTS: We identified 272 SCCC patients based on predefined criteria. The average incidence of SCCC was 1.01 % per year between 2004 and 2015. The median OS and CSS were 17.0 and 19.0 months, respectively, accompanying with 5-year OS rate was 26.3 % and 5-year CSS rate was 30.1 %. In the multivariate analysis, advanced age (age ≥ 65 years old), late FIGO stage, surgery at the primary site, radiotherapy (RT) and chemotherapy (CT) were strong prognostic factors for OS. The corresponding variables for CSS were: advanced age, late FIGO stage, RT and CT. In the subgroup analysis for nonsurgical management of SCCC, the combination of RT and CT provided the best survival outcomes when compared with other therapeutic modalities. Again, advanced age was interrelated to worse survival outcomes for both OS and CSS.
CONCLUSIONS: SCCC is an infrequent disease with aggressive nature, which lead to poor survival outcomes. In addition to other known parameters, advanced age is a strong predictive factor for OS and CSS. The combination of RT and CT was the best therapeutic strategy for patients who received nonsurgical management.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cervix uteri; Clinical outcome; SEER database; Small cell carcinoma

Mesh:

Year:  2020        PMID: 32768799     DOI: 10.1016/j.ejogrb.2020.07.054

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Overexpression of Karyopherin α2 in small cell carcinoma of the cervix correlates with poor prognosis.

Authors:  Ling-Min Liao; Zhen-Bang Gu; Ming Fang; Gong-Ji Yao; Long Huang
Journal:  Int J Clin Exp Pathol       Date:  2022-06-15

2.  Prognostic Analysis and Comparison of the 2014 and 2018 International Federation of Gynecology and Obstetrics Staging System on Overall Survival in Patients with Stage IIB-IVA Cervix Carcinoma.

Authors:  Tao Song; Hong'en Xu; Lei Shi; Senxiang Yan
Journal:  Int J Womens Health       Date:  2022-03-06

3.  Prognostic Value of Radiotherapy and Chemotherapy in Stage I-III Merkel Cell Carcinoma.

Authors:  Aihong Bi; Sifu Yang; Yang Ding; Yong Yu; Wenming Zhan; Tao Song
Journal:  Front Med (Lausanne)       Date:  2022-02-18

4.  A Prognostic Nomogram for Predicting Overall Survival in Patients With Small-Cell Carcinoma of the Uterine Cervix: A SEER Population-Based Study.

Authors:  Yusha Chen; Jiancui Chen; Xiaoqian Lin; Jinwen Zheng; Suyu Li; Xiangqin Zheng
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

5.  A Nomogram-Based Risk Classification System Predicting the Overall Survival of Patients With Newly Diagnosed Stage IVB Cervix Uteri Carcinoma.

Authors:  Wenke Yu; Lu Huang; Zixing Zhong; Tao Song; Hong'en Xu; Yongshi Jia; Jinming Hu; Huafeng Shou
Journal:  Front Med (Lausanne)       Date:  2021-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.